ArticleBlood cancer journal2023

NGS-defined measurable residual disease (MRD) after initial chemotherapy as a prognostic biomarker for acute myeloid leukemia.

Yonghong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.